# OnCo record amnog (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/amnog/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "amnog" ;
  schema:name "AMNOG (Germany, 2011)"@en ;
  schema:alternateName "AMNOG"@en, "Arzneimittelmarktneuordnungsgesetz"@en, "early benefit assessment"@en, "added benefit"@en, "Zusatznutzen"@en, "SGB V section 35a"@en, "GKV-Finanzstabilisierungsgesetz"@en, "Erstattungsbetrag"@en ;
  schema:description "Germany's 2011 law under which a new medicine is sold at the company's price from day one but must show, within six months, how much better it is than the existing standard; the verdict then drives a negotiated price that applies nationwide."@en ;
  schema:url <https://onco.cc/terms/amnog/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/AMNOG> ;
  schema:citation <https://en.wikipedia.org/wiki/AMNOG>, <https://www.g-ba.de/english/benefitassessment/>, <https://www.gesetze-im-internet.de/sgb_5/__35a.html>, <https://www.gesetze-im-internet.de/sgb_5/__130b.html>, <https://www.buzer.de/gesetz/17632/a340690.htm> ;
  onco:tag "law", "de" ;
  onco:related <https://onco.cc/terms/hta/>, <https://onco.cc/terms/eu-hta-regulation/>, <https://onco.cc/terms/nice-methods/>, <https://onco.cc/terms/icer-value-assessment/>, <https://onco.cc/terms/eu-orphan-regulation/>, <https://onco.cc/terms/inflation-reduction-act/>, <https://onco.cc/terms/surrogate-endpoint/>, <https://onco.cc/terms/single-arm/>, <https://onco.cc/terms/france-early-access/> ;
  onco:institutions <https://onco.cc/institutions/g-ba-iqwig/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/> .
